EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Effects of matrix metalloproteinase-14 Inhibition on diabetic Wound Healing

Gui-feng Zeng, Guotian Chen, Zhen Zhou, Shui-lan Zou, Hui-guang Chen, Guo-ping Zhang, Ziyan Yuan, De-hong Pan, Hai-yang Zhou, Gui-Qing Wang, Da-Wei Zhang, Xiao-dan Xia

Experimental and Clinical Endocrinology & Diabetes · 2026-09-04

DOI: 10.1055/a-2943-8604 ↗
AbstractBibliografische Angaben

Abstract

Abstract Matrix metalloproteinases play critical roles in wound repair, yet their context-dependent functions in diabetic wound healing remain elusive. In this study, we found that both the expression and activity of matrix metalloproteinase-14 were significantly elevated in diabetic foot ulcers. Using animal models, we further revealed the dual roles of matrix metalloproteinase-14 in wound healing. In normal rats, inhibition of matrix metalloproteinase-14 delayed wound closure, confirming its supportive role in physiological tissue repair. In contrast, in diabetic rats, pathologically increased matrix metalloproteinase-14 levels impaired healing, whereas moderate inhibition significantly accelerated wound repair. Among the inhibitors tested, the selective matrix metalloproteinase-14 inhibitor NSC405020 produced the most favorable therapeutic effect in diabetic wounds, markedly enhancing healing rates and collagen deposition at a concentration of 1 mg/mL. Compared with the broad-spectrum matrix metalloproteinase inhibitor ND336, NSC405020 demonstrated therapeutic safety and comparable efficacy without notable toxicity in a rat model. Collectively, these findings elucidate the context-dependent role of matrix metalloproteinase-14 in wound healing, suggesting that matrix metalloproteinase-14 may be a promising therapeutic target for diabetic wound healing. Therefore, our study provides a theoretical foundation for the development of effective and safe treatments for diabetic wound management.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →